Hopelessness and complementary therapy use in patients with ovarian cancer

Cancer Nursing

Volumn 36, Issue 4, 2013, Pages 256-264

  Gross, Anne H ^a   Cromwell, Jerry ^c   Fonteyn, Marsha ^a   Matulonis, Ursula A ^b   Hayman, Laura L ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

Author keywords

CAM; Hope; Hopelessness; Massage; Ovarian cancer; Quality of life; Spirituality

Indexed keywords

ADULT; AGE; AGED; ALTERNATIVE MEDICINE; ARTICLE; CANCER RECURRENCE; CANCER SURVIVOR; DISTRESS SYNDROME; EMPLOYMENT; FEMALE; HEALTH BELIEF; HEALTH SURVEY; HOPELESSNESS; HUMAN; MAJOR CLINICAL STUDY; MASSAGE; OVARY CANCER; PATIENT ATTITUDE; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT CANCER; UNITED STATES;

ADAPTATION, PSYCHOLOGICAL; AGED; AGED, 80 AND OVER; COMPLEMENTARY THERAPIES; CROSS-SECTIONAL STUDIES; DEPRESSION; EMOTIONS; FEMALE; HOPE; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; QUALITY OF LIFE; SICKNESS IMPACT PROFILE; SPIRITUALITY; SURVIVORS;

EID: 84880572735     PISSN: 0162220X     EISSN: 15389804     Source Type: Journal    
DOI: 10.1097/NCC.0b013e31826f3bc4     Document Type: Article

References (50)

1. International Federation of Gynecology and Obstetrics. Classification and staging of malignant tumours in the female pelvis. Acta Obstet Gynecol Scand. 1971;50:1-7.
2. Jemal A, Siegel E, Ward E, et al. Cancer statistics. Cancer J Clin. 2008;58:71-96.
3. Von Gruenigen VE, Frasure HE, Jenison EL, Hopkins MP, Gil KM. Longitudinal assessment of quality of life and lifestyle in newly diagnosed ovarian cancer patients: the roles of surgery and chemotherapy. Gynecol Oncol. 2006;103:120-126.
4. Benzein EG, Berg AC. The level of relation between hope, hopelessness and fatigue in patients and family members in palliative care. Palliat Med. 2005;19:234-240.
5. Bodurka-Bevers D, Basen-Engquist K, Camack CL, et al. Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol Oncol. 2000;78:302-308.
6. Lakusta CM, Atkinson MJ, Robinson JW, Nation J, Taezner PA, Campo MG. Quality of life in ovarian cancer patients receiving chemotherapy. J Gynecol Oncol. 2001;81(3):490-495.
7. Ferrell B, Cullinane C, Ervin K, Melancon C, Uman G, Jaurez G. Perspectives on the impact of ovarian cancer: women's views on quality of life. Oncol Nurs Forum. 2005;32(6):1143-1149.
8. McClement SE, Chochinov HM. Hope in advanced cancer patients. Eur J Cancer. 2008;44:1169-1174.
9. Farran C, Herth K, Popovich J. Hope and Hopelessness: Critical Clinical Constructs. Thousand Oaks, CA: Sage Publications; 1995.
10. Butt C. Hope in adults with cancer: state of the science. Oncol Nurs Forum. 2011;38(5):E341-E350.
11. Brothers B, Andersen B. Hopelessness as a predictor of depressive symptoms for breast cancer patients coping with recurrence. Psychooncology. 2009;18:267.
12. Dunn S. Hopelessness as a response to physical illness. J Nurs Scholarsh. 2005;37:148-154.
13. Beck AT, Weissman A. The measurement of pessimism: the Hopelessness Scale. J Consult Clin Psychol. 1974;42(6):861-865.
14. Cassileth BR, Schraub S, Robinson E, Vickers A. Alternative medicine use worldwide. Cancer. 2001;91:1390-1393.
15. Mystakidou K, Tsilka E, Parpa E, Pathiaki E, Galanos A, Vlahos L. Exploring the relationships between depression, hopelessness, cognitive status, pain and spirituality in patients with advanced cancer. Arch Psychiatr Nurs. 2007;21(3):150-161.
16. Matulonis UA. Long-term adjustment of early-stage ovarian cancer survivors. Int J Gynecol Cancer. 2008;18:1183-1193.
17. Mystakidou K, Tsilika E, Parpa E, et al. Demographic and clinical predictors of spirituality in advanced cancer patients: a randomized control study. J Clin Nurs. 2008;17(13):1779-1785.
18. Hammer K, Mogenson O, Hall E. Hope as experienced in women newly diagnosed with gynaecological cancer. Eur J Oncol Nurs. 2009;13:274-279.
19. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998;280(18):1569-1575.
20. Verhoef MJ, Balneaves LG, Boon H, Vroegindewey BN. Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systemic review. Integr Cancer Ther. 2005;4(4):274-286.
21. McKay DJ, Bentley J, Grimshaw R. Complementary and alternative medicine in gynaecologic oncology. J Obstet Gynaecol Canada. 2005;6:562-568.
22. Richardson MA, Sanders T, Palmer L, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000;18(13):2505-2514.
23. Helpman L, Ferguson S, MackeanM, et al. Complementary and alternative medicine use among women receiving chemotherapy for ovarian cancer in 2 populations. Int J Gynecol Cancer. 2011;21(3):587-593.
24. Mirabeau-Beale K, Kornblith A, Penson R, et al. Comparison of the quality of life of early and advanced stage ovarian cancer survivors. Gynecol Oncol. 2009;114:353-359.
25. Ben-Ayre E, Frenkel M, Margalit RS. Approaching complementary and alternative medicine use in patients with cancer. Questions and challenges. J Ambul Care Manage. 2004;27(1):53-62.
26. Barnes PM, Bloom B, Nahin R. Complementary and alternative medicine use among adults and children: United States, 2007. National Health Statistics Reports, US Department of Health and Human Services, Center for Disease Control and Prevention. National Health Statistics. 12:1-23. http://nccam.nih.gov/news/ 2008/nhsr12.pdf. Accessed December 10, 2008.
27. Yates JS, Mustian K, Morrow G, et al. Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer. 2005;13:806-811.
28. Navo MA, Phan J, Vaughan C, et al. An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol. 2004;22:671-677.
29. Russell G, Fawcett J. The conceptual model for nursing and health policy. Policy Polit Nurs Pract. 2005;6/4:319-326.
30. Accessed January 29, 2012 http://www.ons.org/media/ons/docs/research/ researchagenda-2009-2013.pdf ONS.org.
31. NCCAM.org. 2012. http://www.nih.gov/about/almanac/organization/NCCAM.htm. Accessed January 29, 2012.
32. Pattison N, Lee C. Hope against hope at the end of life. J Religion Health. 2011;50:731-742.
33. Peterman AH, Fitchett G, Brady MJ, Hernandez L, Cella D. Measuring spiritual well-being in people with cancer: the Functional Assessment of Chronic Illness TherapyYSpiritual Well-being Scale (FACIT-Sp). Ann Behav Med. 2002;2(1):49-58.
34. Stewart AL, Ware JE Jr. Measuring Functioning and Well-being in General Populations: The Medical Outcomes Study Approach. Durham, NC: Duke University Pres0073; 1992.
35. Greimel E, Bottomley A, Cull A, et al. D'haese on behalf of the EORTC Quality of Life Group and the Quality of Life unit. Eur J Cancer. 2003; (39):1402-1408.
36. Cull A, Howat S, Greimel E, et al, on behalf of the European Organization for Research and Treatment for Cancer (EORTC) Quality of Life Group and the Scottish Gynaecological Cancer Trials Group. Development of an EORTC questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials: a progress report. Eur J Cancer. 2001;37:47-53.
37. Sollner W, Maislinger S, DeVries A, Steixner E, Rumphold G, Lukas P. Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey. Cancer. 2003;89(4):873-880.
38. Gross AH, Cromwell J, Kornblith AB, et al. Effects of Complementary and Alternative Medicine Use on Hopelessness in Ovarian Cancer Patients. Presented at the American Society of Clinical Oncology (ASCO), Annual Scientific Meeting; Chicago, Illinois; June 2008.
39. Vellone E, Rega ML, Galletti C, Cohen M. Hope and related variables in Italian cancer patients. Cancer Nurs. 2006;29(5):365-366.
40. Gustavsson-Lillius M, Julkunen J, Hietanen P. Quality of life in cancer patients: the role of optimism, hopelessness, and partner support. Qual Life Res. 2006;16:75-87.
41. Gotheridge SM, Dresner N. Psychological adjustment to gynecologic cancer: treatment decision making for ovarian cancer patients. J Gynecol Oncol. 2003;88:89-95.
42. Penson RT, Wenzel LB, Vergote I, Cella D. Quality of life considerations in gynecologic cancer. Int J Gynecol Obstet. 2006;95:S247-S257.
43. Cassileth BR, Trevisan C, Gubbili J. Complementary therapies for cancer pain. Curr Pain Headache Rep. 2004;11(4):265-269.
44. Smith M, Yamashita T, Bryant L, Hemphill L, Kutner J. Providing massage therapy for people with advanced cancer: what to expect. J Altern Complement Med. 2009;15(4):367-371.
45. Jane S, Wilkie D, Gallucci B, Beaton R. Systematic review of massage intervention for adult oncology patients with cancer. Cancer Nurs. 2008; 31(6):24-34.
46. Ernst E. Massage therapy for cancer palliation and supportive care: a systematic review of randomized clinical trials. Support Cancer Care. 2009;17: 333-337.
47. Pehlivan S, Ovayolu N, Sevinc A, Camci C. Relationship between hopelessness, loneliness, and perceived social support from family in Turkish patients with cancer. Support Care Cancer. 2011;20(4):733-739.
48. Herth K, Cutliffe J. The concept of hope in nursing 1: its origins, background and nature. Br J Nurs. 2002;11(12):832-840.
49. Mystikadou K, Parpa E, Tsilka E, et al. Preparatory grief, psychological distress and hopelessness in advanced cancer patients. Eur J Cancer Care. 2008;17:145-151.
50. Reb AM. Transforming the death sentence: elements of hope in women with ovarian cancer. Oncol Nurs Forum. 2007;34(6):E70-E81.